COVID-19 Impact - BMT

Use the RX TEXT--BMT field to record information about bone marrow/stem cell delays, discontinuation, or modifications due to COVID-19.

Note: Record the following information for all cancer patients (when applicable) regardless of whether or not they have a COVID-19 diagnosis or test.

1. When medical documentation is available to indicate that bone marrow/stem cell transplant administration was discontinued or not initiated because of COVID-19 pandemic, record
   1. BMT DC D/T COVID-19
2. When medical documentation is available to indicate that bone marrow/stem cell transplant administration was changed because of COVID-19 pandemic, record
   1. BMT CHG D/T COVID-19
3. When medical documentation is available to indicate that initiation of bone marrow/stem cell transplant administration was delayed because of COVID-19 pandemic. record
   1. BMT DELAYED D/T COVID-19
4. When medical documentation is available to indicate that bone marrow/stem cell transplant administration was changed/modified from what is typically recommended and delayed due to COVID-19, record
   1. BMT CHG & DELAYED D/T COVID-19
5. When bone marrow/stem cell transplant was recommended before but administered after disease progression, record
   1. BMT delayed D/T COVID-19 & given as subsequent TX after progression
   2. Note: Record BMT treatment in Second Course Rx fields